HomeGLMD • NASDAQ
Follow
Galmed Pharmaceuticals Ltd
Previous close
$0.34
Day range
$0.32 - $0.35
Year range
$0.26 - $7.80
Market cap
1.39M USD
Avg Volume
200.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.47M | -72.71% |
Net income | -1.47M | 72.47% |
Net profit margin | — | — |
Earnings per share | -0.24 | 92.38% |
EBITDA | -1.46M | 72.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.31M | -30.71% |
Total assets | 17.64M | -15.48% |
Total liabilities | 2.09M | -59.16% |
Total equity | 15.55M | — |
Shares outstanding | 4.01M | — |
Price to book | 0.09 | — |
Return on assets | -23.74% | — |
Return on capital | -28.12% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -1.47M | 72.47% |
Cash from operations | -2.18M | 30.09% |
Cash from investing | -3.54M | -168.98% |
Cash from financing | 6.18M | 8,735.71% |
Net change in cash | 473.00K | -77.27% |
Free cash flow | -1.97M | -24.17% |
About
Founded
2000
Website
Employees
7